Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers

Clinical trial NCT02252211 · COMPLETED

Trial details

NCT number: NCT02252211
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor Metastatic EphA2 Positive Cancer

Start date: 2014-12-09
Primary completion: 2016-09-08
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.